DGX•benzinga•
Quest Diagnostics Provides Long-term Outlook Beyond 2025: Sees Revenues Compound Annual Growth Rate (CAGR) Of 4%-5%, Adjusted EPS Growth At 7%-9%
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 19, 2025 by benzinga